Applications of (2S,6R)-6-Amino-2-(2-Thienyl)-1,4-Thiazepan-5-One in Industrial Manufacturing

As a direct manufacturer, we supply (2S,6R)-6-Amino-2-(2-Thienyl)-1,4-Thiazepan-5-One to a focused set of advanced industrial customers. This chiral thiazepanone compound supports the synthesis of distinctive functional molecules, especially within regulated pharmaceutical and fine chemical sectors. We document real-world adoption throughout the pharmaceutical intermediate, specialty chemical, peptide modification, and agrochemical synthesis industries. Each pathway imposes specific requirements for compliance, composition, process integration, and end product definition, as detailed below.

1. Pharmaceutical Intermediate Synthesis

Manufacturers utilize this compound as a chiral intermediate for complex heterocyclic active pharmaceutical ingredient (API) synthesis, especially for developing beta-lactamase-resistant antibiotics and proprietary CNS therapeutics. The unique configuration supports enantioselective construction steps during scale-up and production campaigns. Standard protocols require kinetic resolution and multi-step transformation with direct inclusion into amidation or cyclization reactions, where strict quality and consistency drive repeat purchasing from regulated markets.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for APIs
• EU EudraLex Volume 4 Annex 1 (Sterile Medicinal Products)
• US FDA 21 CFR Part 211 (cGMP for Finished Pharmaceuticals)
• Japanese Pharmacopoeia (JP) standards for intermediates

Typical usage ratio

• 5-12 mol% of total API batch input, adjusted per synthetic route and required enantiopurity

Downstream process integration

• Direct input in chiral ring-closure steps during pre-final intermediate formation
• Used at the enantioselective amination stage for specific cephalosporin derivatives

Final product types

• Third-generation cephalosporin APIs
• Specialty CNS medication intermediates
• Patented beta-lactamase inhibitor scaffolds

2. Peptide and Protein Engineering

Research and cGMP manufacturers incorporate this thiazepane derivative for the site-selective modification of peptides and small proteins, enabling backbone cyclization and uncommon thioamide bond introduction. The cyclic structure supports increased proteolytic stability and targeted pharmacokinetics in bioconjugate pharmaceuticals. The integration protocol requires strict control of stoichiometry during on-resin or solution-phase coupling steps, with batch records supporting full traceability for regulatory audits.

Industry compliance standards

• ISO 13485 (Medical Device QMS) for conjugated peptide production
• US FDA Guidance for Industry: Q11 (Development and Manufacture of Drug Substances)
• USP General Chapter <1047> Peptides

Typical usage ratio

• 0.5–2 equivalents per modification site on peptide backbone

Downstream process integration

• Covaluent attachment and cyclization during solid-phase peptide synthesis (SPPS)
• In-line monitoring of coupling yields and by-product removal via HPLC

Final product types

• Macrocyclic peptide drugs
• Peptide-drug conjugates (PDCs) for targeted oncology treatment
• Stabilized peptide biomarkers for in vitro diagnostics

3. Specialty Heterocycle Building for Fine Chemicals

Chemical manufacturers adopt this compound as a core building block for synthesizing extended heterocyclic structures, underpinning the development of advanced fine chemicals, photoinitiators, and custom ligands for industrial catalysis. The reactive amino and thienyl groups facilitate direct extension and functionalization without excessive protection-deprotection cycles, streamlining downstream process times and reducing batch impurities for critical performance materials.

Industry compliance standards

• REACH (EC) No 1907/2006 for specialty chemical substances in European Union
• ISO 9001 Quality Management System for precision fine chemical production
• Responsible Care Global Charter for safe chemical handling

Typical usage ratio

• 10–25 mol% based on backbone length or as a limiting reagent for exact ring count

Downstream process integration

• Reaction start material for multi-step heterocycle construction
• Feeding directly into Suzuki or Buchwald–Hartwig cross-coupling batch reactors

Final product types

• Photoactive specialty chemicals
• Custom aromatic ligands for industrial homogeneous catalysis
• Performance monomers for conductive polymers

4. Agrochemical Active Ingredient Synthesis

Large-scale agrochemical producers select this material as a precursor for constructing novel fungicidal and insecticidal heterocyclic actives, where the thienyl-thiazepane motif imparts selective binding to pest molecular targets. Process engineers apply it downstream in functionalization and halogenation steps, meeting high standards for traceability, environmental safety, and product registration in tightly regulated agricultural markets.

Industry compliance standards

• FAO/WHO Guidelines for the Quality Control of Pesticides
• OECD Principles of Good Laboratory Practice (GLP)
• EPA 40 CFR Part 158 (Data Requirements for Pesticide Registration)

Typical usage ratio

• 3–10 mol% of total batch input, modified according to target heterocycle ring system

Downstream process integration

• Feedstock for chlorination or thioetherification steps in bulk synthesis
• In-line monitoring using mass spectrometry for impurity profile control

Final product types

• Next-generation systemic fungicides
• Heterocyclic insecticidal agrochemical actives
• Seed protection agents for crop management